Cargando…

Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study

BACKGROUND: This study used quantitative and qualitative research methods to analyze how acute hepatic porphyria (AHP) affects patients with varying annualized porphyria attack rates. The overall impact of AHP on patients and caregivers, including their quality of life, was explored. The nature and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Liz, Burrell, Sue, Chamberlayne, John, Lombardelli, Stephen, Mora, Jordanna, Mason, Nicola, Schurer, Marieke, Merkel, Madeline, Meninger, Stephen, Ko, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074407/
https://www.ncbi.nlm.nih.gov/pubmed/33902669
http://dx.doi.org/10.1186/s13023-021-01816-2
_version_ 1783684347508817920
author Gill, Liz
Burrell, Sue
Chamberlayne, John
Lombardelli, Stephen
Mora, Jordanna
Mason, Nicola
Schurer, Marieke
Merkel, Madeline
Meninger, Stephen
Ko, John J.
author_facet Gill, Liz
Burrell, Sue
Chamberlayne, John
Lombardelli, Stephen
Mora, Jordanna
Mason, Nicola
Schurer, Marieke
Merkel, Madeline
Meninger, Stephen
Ko, John J.
author_sort Gill, Liz
collection PubMed
description BACKGROUND: This study used quantitative and qualitative research methods to analyze how acute hepatic porphyria (AHP) affects patients with varying annualized porphyria attack rates. The overall impact of AHP on patients and caregivers, including their quality of life, was explored. The nature and treatment of acute attacks, experiences of long-term heme arginate treatment and access to other appropriate treatment, and the extent of and treatment for chronic symptoms were also investigated within this study. METHODS: Patient and caregiver data were collected via an online survey of members of the British Porphyria Association, followed by an optional 1-h telephone interview. RESULTS: Thirty-eight patients and 10 caregivers responded to the survey. Of those, 10 patients and three caregivers completed follow-up interviews. Overall, 19 patients (50%) had experienced an acute attack within the previous 2 years, and the severity and types of symptoms experienced during or between acute attacks varied considerably. There were no clear definitions among patients for ‘mild’ or ‘severe’ attacks. Treatments and treatment settings used to manage attacks also varied. Following unsatisfactory care experiences at hospitals, some patients reported avoiding further hospital services for later attacks. Therefore, using settings of care as a measure of attack severity should be avoided. Ninety-four percent of patients also experienced chronic symptoms, which were as varied as acute attacks. Pain was the predominant chronic symptom and was managed with opioids in severe cases. Regardless of AAR, porphyria heavily impacted the daily lives of patients and caregivers. Although patients experiencing frequent attacks generally endured a greater impact on their daily life, patients with less frequent attacks also experienced impacts on all domains (social, leisure activities, relationship with family, relationships, psychological wellbeing, finances, employment, and study). Caregivers were most affected in the finance, relationships with family, and employment domains, and just over half of the caregivers reported a moderate impact on their psychological wellbeing. CONCLUSIONS/IMPLICATIONS: The burden of illness with AHP is high across all patients, regardless of frequency of attacks, and AHP negatively affects patients and caregivers alike. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01816-2.
format Online
Article
Text
id pubmed-8074407
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80744072021-04-26 Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study Gill, Liz Burrell, Sue Chamberlayne, John Lombardelli, Stephen Mora, Jordanna Mason, Nicola Schurer, Marieke Merkel, Madeline Meninger, Stephen Ko, John J. Orphanet J Rare Dis Research BACKGROUND: This study used quantitative and qualitative research methods to analyze how acute hepatic porphyria (AHP) affects patients with varying annualized porphyria attack rates. The overall impact of AHP on patients and caregivers, including their quality of life, was explored. The nature and treatment of acute attacks, experiences of long-term heme arginate treatment and access to other appropriate treatment, and the extent of and treatment for chronic symptoms were also investigated within this study. METHODS: Patient and caregiver data were collected via an online survey of members of the British Porphyria Association, followed by an optional 1-h telephone interview. RESULTS: Thirty-eight patients and 10 caregivers responded to the survey. Of those, 10 patients and three caregivers completed follow-up interviews. Overall, 19 patients (50%) had experienced an acute attack within the previous 2 years, and the severity and types of symptoms experienced during or between acute attacks varied considerably. There were no clear definitions among patients for ‘mild’ or ‘severe’ attacks. Treatments and treatment settings used to manage attacks also varied. Following unsatisfactory care experiences at hospitals, some patients reported avoiding further hospital services for later attacks. Therefore, using settings of care as a measure of attack severity should be avoided. Ninety-four percent of patients also experienced chronic symptoms, which were as varied as acute attacks. Pain was the predominant chronic symptom and was managed with opioids in severe cases. Regardless of AAR, porphyria heavily impacted the daily lives of patients and caregivers. Although patients experiencing frequent attacks generally endured a greater impact on their daily life, patients with less frequent attacks also experienced impacts on all domains (social, leisure activities, relationship with family, relationships, psychological wellbeing, finances, employment, and study). Caregivers were most affected in the finance, relationships with family, and employment domains, and just over half of the caregivers reported a moderate impact on their psychological wellbeing. CONCLUSIONS/IMPLICATIONS: The burden of illness with AHP is high across all patients, regardless of frequency of attacks, and AHP negatively affects patients and caregivers alike. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01816-2. BioMed Central 2021-04-26 /pmc/articles/PMC8074407/ /pubmed/33902669 http://dx.doi.org/10.1186/s13023-021-01816-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gill, Liz
Burrell, Sue
Chamberlayne, John
Lombardelli, Stephen
Mora, Jordanna
Mason, Nicola
Schurer, Marieke
Merkel, Madeline
Meninger, Stephen
Ko, John J.
Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study
title Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study
title_full Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study
title_fullStr Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study
title_full_unstemmed Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study
title_short Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study
title_sort patient and caregiver experiences of living with acute hepatic porphyria in the uk: a mixed-methods study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074407/
https://www.ncbi.nlm.nih.gov/pubmed/33902669
http://dx.doi.org/10.1186/s13023-021-01816-2
work_keys_str_mv AT gillliz patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT burrellsue patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT chamberlaynejohn patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT lombardellistephen patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT morajordanna patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT masonnicola patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT schurermarieke patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT merkelmadeline patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT meningerstephen patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy
AT kojohnj patientandcaregiverexperiencesoflivingwithacutehepaticporphyriaintheukamixedmethodsstudy